Immupharma Share Discussion Threads

[hamhamham1] 21/2/2018 14:31

If a bargain come along then fine but they are few and far between, most people want crazy money.
Besides most everything is over valued at the mo. I like a quick dip, flip and bank in this climate.
There will come a time I think over the next couple of years when cash will be king.
Then those will be happy days.
What do I know?

[albanyvillas] 21/2/2018 14:27

interesting to see broker 700 target

[arcadian] 21/2/2018 14:26

Ham1

Why not take it up full time?

[scrutable] 21/2/2018 14:26

This is a binary situation. The share price after publication of the results will jump according to the legion of soothsayers here, to at least above 200p on the first day and at anything up to 500p, A negative result could lose 90% and finish the day at 10-15p according to what fly was said to having been found in the ointment.

BUT NOWHERE CAN I FIND THE TROLLS DEFINING WHAT KIND OF FLY! What could it look like? and why has noone tried or been able to define it? My own feeling is that the downside risk is undefined. Its damage potential overvalued and that it is a very small fly . Which makes the decision to buy or sell unsymmetrical, and led to my doubling and redoubling my share of funds to 30% applied to IMM in my portfolio, and at the same level as OXB, which offers a higher certainty from a much smaller pot, but I am increasingly confident and will probably again sell weaker shares and increase IMM to 40%. Albeit that it is against my principles to arrange such an out-of -balance.

This really is the share of my lifetime..

Let's debate the real risk in each case. I believe that the long term upside, after modifying and commercialising the other indications is $20+ billion with a probablity of say,only 10%. THE CONTROLLING SHAREHOLDERS WOULD HAVE GOT TOO IMPATIENT BY THEN, or $10 Billion reflecting its superiority to Benlysta, and a probability of 40%-70% again depending on impatience and other hurdles

On another matter: the spikes and gap-ups always lead to an approx 40% Fibonacci pull back ie from the first day's 200-500p -towards 170p - 350p, before resuming the climb, as the timidest of holders, mostly neophytes, dart forward to trouser their good luck. This type of pattern should repeat itself more or less strongly, depending on the news flow, which at this point is completely unpredictable at least during the next 12 months, during which potential acquirers and the directors show their hand which for the lupus rights alone $8-$10billion is not fanciful after the Benlysta deal.

[che7win] 21/2/2018 14:26

Chadders, What will they pay for Nucant that has been shown to be effective in reducing tumours? This is very promising and is separate from Lupuzor and the P140 platform.Apart from that, Lupuzor is only one strand of the P140 platform.In other words, if phase3 is successful, Lupuzor will not be the only target, the whole P140 platform for other diseases will come under scrutiny.Exponential increases in share price isn't a multibagger from here, it's starting at the £30 per share level.This is being underplayed.

[hamhamham1] 21/2/2018 14:22

Yep agree. Am mostly waiting to see how markets play out, hence why only in this one share currently.
But still can make on property, I bought a flat last May, done it up and sold it, exchange tomorrow. Made net 22% profit after all costs. But it's getting hard. It's all in the buy price currently.

[costax1654x] 21/2/2018 14:21

Remember Lanstead will not jump in a placing without any extra info .Placing price is still above current price!

[arcadian] 21/2/2018 14:20

Che

Do you think that there could be any better way of announcing the Phase3 Facts other than a painful series of days when there just might or might not be an RNS?

I was struck yesterday by the pain for UKOG investors when there was a mid afternoon RNS.

[chadders] 21/2/2018 14:18

Just for the record, big pharma will pay big bucks pre FDA and offer bigger bucks dependent upon FDA approval and realised sales.

28.08.17

"Gilead is spending $12 billion to buy Kite Pharma, a biotech that has no approved therapies yet.

The drugmaker's therapy that's a few months away from a possible approval is a highly personalized cancer treatments called CAR T-cell therapy. It's a form of cancer immunotherapy — or a therapy that harnesses the body's immune system to take on cancer cells"

[flavio_monteiro] 21/2/2018 14:17

hamhamham1... the slight difference is.... that we private investors are speculators, The risks are higher and so are the rewards. All shares are risky Mr Ham.

But the greatest rewards are bestowed to those who take risks, are patient and are well researched.

In the past anyone could have bought a house and made money....but buying a house now is a risk.

Not everyone can make money on the stockmarket. One could accept 0,2% interest in a Bank Account for Zero Risk!

[costax1654x] 21/2/2018 14:16

Not many chances in life to multiply the money so fast.If all good is going to change our life!

[che7win] 21/2/2018 14:14

One thing, Nucants is going to dwarf Lupuzor.

[costax1654x] 21/2/2018 14:13

Easy money next days here!!145 by Friday for sure!!!Maybe more.It might go back to 190 before Results!!!And if what they reckon 5,6,7£ !FDA and commercial parter...another story 10£?

[cockerspaniel] 21/2/2018 14:03

squire:
I wouldn't take any notice of people expecting the entire upside to happen in one day.

[hamhamham1] 21/2/2018 14:02

Flavio. I agree. Especially like the use of the word 'risk'.
That word applies to investors of all levels.

[flavio_monteiro] 21/2/2018 13:57

Its about risk, no pharma will pay big bucks before FDA approval.

Its too risky and as NJB67 rightly put it "Their jobs will be at risk"

They will be happy to pay more after!!

[divinessence] 21/2/2018 13:49

Falvio - Agree but it all depends what is on the table?

[flavio_monteiro] 21/2/2018 13:47

divinessence - Best Value gained for IMM + Investors AFTER FDA Approval ....Not Before!

[divinessence] 21/2/2018 13:45

The fact that they haven't (so far) done deal prior to Phase 3 results shows they are confident of success, hence all deals may come after the results to put them in even more stronger position. Looking promising imho.

[flavio_monteiro] 21/2/2018 13:43

You noticed wigwammer Dame!

[mad foetus] 21/2/2018 13:42

I must say, if there were 90% fewer posts this company would attract more investors. I have a small holding, but, along with VRS and UKOG, this must be the most irritating B.B. on ADVFN. It puts people off what I think is a great investment opportunity.

[hamhamham1] 21/2/2018 13:42

Wig. Quick buy some more shares before they hit £30.

[wigwammer] 21/2/2018 13:32

Flávio... stop picking on people who repeatedly add NO value! :)

[lodgeview] 21/2/2018 13:30

Act fast folks. Once they're gone they're gone!